Related Experiment Video
Updated: May 9, 2026
07:22
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Incontinence-associated dermatitis in the elderly: treatment options
Eleanor Corcoran1, Sue Woodward
1Florence Nightingale School of Nursing and Midwifery, King's College, London, UK.
British Journal of Nursing (Mark Allen Publishing)
|August 3, 2013
Summary
Incontinence-associated dermatitis (IAD) management lacks clear guidance on barrier products. More research is needed to determine the most effective barrier products for preventing and treating IAD in older adults.
Area of Science:
- Dermatology
- Gerontology
- Nursing
Background:
- Incontinence-associated dermatitis (IAD) is prevalent in older adults.
- IAD is often misdiagnosed and inadequately treated, leading to uncertainty regarding product selection and application.
- Existing literature lacks definitive guidance on optimal barrier product use for IAD.
Purpose of the Study:
- To review the literature on barrier products for the prevention and treatment of IAD.
- To compare and contrast the effectiveness of various barrier products based on available research.
- To identify gaps in the evidence regarding barrier product efficacy for IAD.
Main Methods:
- A systematic literature search was conducted to identify primary research papers.
- Six relevant research papers analyzing the effectiveness of barrier products were included.
- The identified studies were compared and contrasted to synthesize findings.
Main Results:
- There is insufficient evidence to recommend one barrier product over another for standardized IAD skincare protocols.
- Current research does not definitively establish the most effective barrier products available.
- More studies are needed specifically on IAD, distinct from studies that combine IAD with pressure ulcers.
Conclusions:
- Further research is essential to guide the selection and application of barrier products for IAD.
- Evidence-based recommendations for barrier product use in IAD prevention and treatment are currently lacking.
- Future studies should focus exclusively on IAD to clarify the efficacy of different barrier products.
Related Concept Videos
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...